caption
stringlengths 6
2.51k
|
|---|
The molecule is a emulsifier, nutrient, inflammatory, energy source. The molecule is a surfactant, energy storage, membrane stabilizer, signalling molecule that impacts metabolic syndrome. |
The molecule is a nutrient. |
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and aging. |
The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting cardiovascular disease. The molecule is a fat storage that impacts atherosclerosis, pancreatitis, and metabolic syndrome. |
The molecule is a stabilizing mitochondrial structure, a membrane stabilizer, and a proton trap for oxidative phosphorylation, and it impacts aging. The molecule is a apoptosis, a stabilizing cytochrome oxidase, and a surfactant, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a energy source and a emulsifier, impacting both diabetic heart disease and tangier disease. The molecule is a nutritional supplement, cholesterol translocation, energy storage, food additive that impacts barth syndrome. |
The molecule is anti depressant. |
The molecule is a serotonin reuptake inhibitor and tachykinin receptor antagonist, belonging to both the tachykinin antagonist and anti depressant classes of molecules, and is cns disorder treatment. |
The molecule has Odorless. |
The molecule is a nutrient, fat storage, membrane stabilizer that impacts atherosclerosis, cardiovascular disease, and metabolic syndrome. The molecule is a energy storage and energy source, and it impacts obesity. The molecule is a inflammatory and belongs to the thyroxine treatment class of molecules, impacting both cancer and pancreatitis. |
It belongs to the anti bacterial, anti tumor, and anti tumour classes of molecules. |
The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts aging, tangier disease, and barth syndrome. The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and diabetic heart disease. |
It belongs to the hypertension treatment class of molecules. |
The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts diabetic heart disease, aging, non-alcoholic fatty liver disease, and tangier disease. |
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts aging and tangier disease. |
The molecule is both a pi3k inhibitor and a cancer treatment. |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, diabetic heart disease, and tangier disease. |
It impacts insulin resistance. |
The molecule is thyroxine treatment and it impacts both atherosclerosis and cardiovascular disease. The molecule is a fat storage and a nutrient, impacting both pancreatitis and metabolic syndrome. |
The molecule is a membrane stabilizer, energy source, and thyroxine treatment that has an effect on cancer and impacts both metabolic syndrome and atherosclerosis. The molecule is a fat storage and nutrient, and it impacts obesity. The molecule is a energy storage and a inflammatory, impacting both cardiovascular disease and pancreatitis. |
It belongs to the anti microbial class of molecules. |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts barth syndrome, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts diabetic heart disease and aging. |
The molecule is a membrane stabilizer, surfactant, energy storage, emulsifier, energy source, nutrient. |
The molecule is a anti viral. |
The molecule is a anti microbial member of the anti bacterial class. |
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis. |
The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts aging, diabetic heart disease, and tangier disease. |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure that impacts aging and barth syndrome. |
The molecule is a kinase inhibitor. |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, stabilizing mitochondrial structure that impacts aging and barth syndrome. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and barth syndrome. |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging. The molecule is a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, tangier disease, and barth syndrome. |
The molecule is a nutritional supplement and a proton trap for oxidative phosphorylation, impacting both barth syndrome and tangier disease. The molecule is a apoptosis, stabilizing mitochondrial structure, energy storage, membrane stabilizer, and smooth. The molecule is a surfactant, a cholesterol translocation, and a food additive, and it impacts diabetic heart disease. The molecule is a energy source, stabilizing cytochrome oxidase, emulsifier that impacts non-alcoholic fatty liver disease and aging. |
The molecule is a energy storage that impacts diabetes mellitus, breast cancer, and stomach cancer. The emulsifier molecule affects colorectal cancer, impacts alzheimer's disease, and is smooth. The molecule is a energy source, a nutritional supplement, and a membrane stabilizer, and it impacts seizure. The molecule is a signalling molecule, surfactant, food additive that impacts cardiovascular disease and parkinson's disease. |
It impacts insulin resistance, neurodegenerative disease, and diabetes mellitus. |
The molecule is a hcv inhibitor. |
The molecule is a thrombin inhibitor, nmda antagonist, factor xa inhibitor, anti coagulant and belongs to the allergic disease treatment class of molecules. |
The molecule is both a erk inhibitor and a hcv protease inhibitor. |
The molecule is a anti viral activity and a hepatitis c treatment, belonging to the anti viral class of molecules. |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and aging. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, barth syndrome, and tangier disease. |
The molecule is a surfactant, a emulsifier, a membrane stabilizer, and smooth. The molecule is a nutritional supplement, energy storage, apoptosis that impacts diabetic heart disease and tangier disease. The molecule is a cholesterol translocation and a energy source, impacting both barth syndrome and aging. The molecule is a food additive, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. |
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, diabetes mellitus type 2, alzheimer's disease, and parkinson's disease. |
The molecule is a nutritional supplement, a food additive, and a proton trap for oxidative phosphorylation, and it impacts diabetic heart disease. The molecule is a emulsifier, membrane stabilizer, stabilizing mitochondrial structure, energy source, and smooth. The molecule is a stabilizing cytochrome oxidase, a surfactant, and a energy storage, and it impacts aging. The molecule is a apoptosis and a cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, and barth syndrome. |
The molecule is a energy storage, fat storage, energy source that impacts metabolic syndrome, atherosclerosis, and obesity. The molecule is a inflammatory and thyroxine treatment, and it impacts pancreatitis. The molecule is a nutrient and a membrane stabilizer, with effects on cancer and impacts on cardiovascular disease. |
The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts tangier disease, non-alcoholic fatty liver disease, and aging. |
The molecule is a flavoring agent that is nutty and earthy. The molecule is raw, potato, roasted, and strong. |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease. The molecule is a apoptosis that impacts aging, barth syndrome, non-alcoholic fatty liver disease, and tangier disease. |
The molecule is a anti asthmatic member of the anti epileptic class. |
The molecule is a kinase inhibitor. |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts aging and barth syndrome. |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, tangier disease, barth syndrome, and aging. |
The molecule is a energy storage, fat storage, nutrient, energy source that impacts cardiovascular disease and obesity. The molecule is a thyroxine treatment and membrane stabilizer with an effect on cancer. The molecule is a inflammatory that impacts metabolic syndrome, pancreatitis, and atherosclerosis. |
The molecule is anti bacterial. |
The molecule is anti tumor. |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts barth syndrome, tangier disease, and diabetic heart disease. |
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure that impacts barth syndrome and tangier disease. |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. |
The molecule is a fat storage and nutrient, and it impacts cardiovascular disease. The molecule is a member of the thyroxine treatment class and affects atherosclerosis, metabolic syndrome, and pancreatitis. |
The molecule is a angiogenesis inhibitor and a protein tyrosine kinase inhibitor, belonging to the neurodegenerative disease treatment class of molecules, impacts psychiatric treatment, and is neurological treatment. |
The molecule is a organic light-emitting device and belongs to the electronic device class of molecules. |
The molecule is a fat storage, energy source, energy storage that impacts atherosclerosis, cancer, and obesity. The molecule is a nutrient that impacts both cardiovascular disease and pancreatitis. The molecule is a thyroxine treatment, a inflammatory, and a membrane stabilizer, and it impacts metabolic syndrome. |
The molecule is a membrane stabilizer, fat storage, nutrient, inflammatory that impacts cardiovascular disease and pancreatitis. The molecule is a energy source and energy storage, and it impacts obesity. The molecule is thyroxine treatment and impacts atherosclerosis, cancer, and metabolic syndrome. |
The molecule is a member of the organic electroluminescent material, luminescent, and electroluminescent classes and has an effect on organic electroluminescence, while being light-emitting. |
The molecule is both a anti inflammatory and a serine protease inhibitor. |
The molecule is a prostaglandin inhibitor and belongs to the anti inflammatory class of molecules. |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts barth syndrome and aging. |
The molecule has Odorless. When heated to decomposition it emits toxic fumes of nitrogen oxides. |
The molecule is a factor xa inhibitor and fxa inhibitor, belonging to both the anti coagulant and cardiovascular disease treatment classes of molecules. |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and tangier disease. |
The molecule is a energy source, nutrient, energy storage, fat storage that has an effect on cancer and impacts pancreatitis. The molecule is a member of the thyroxine treatment class and affects both obesity and metabolic syndrome. The molecule is a membrane stabilizer and a inflammatory, impacting both atherosclerosis and cardiovascular disease. |
The molecule has Odorless. |
The molecule is a protease inhibitor and is hiv treatment. |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging and barth syndrome. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. |
The molecule is a inflammatory, energy source, energy storage, fat storage, membrane stabilizer, nutrient. It impacts metabolic syndrome, pancreatitis, and obesity. It is a member of the thyroxine treatment class of molecules that affects cancer and has an impact on both cardiovascular disease and atherosclerosis. |
The molecule is a fat storage that impacts obesity, cancer, thyroxine treatment, atherosclerosis, and pancreatitis. The molecule is a energy storage and nutrient, and it impacts metabolic syndrome. The molecule is a membrane stabilizer, a energy source, and a inflammatory, and it impacts cardiovascular disease. |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, barth syndrome, and tangier disease. |
The molecule is a nutrient that impacts diabetes mellitus type 2, parkinson's disease, alzheimer's disease, and non-alcoholic fatty liver disease. |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts diabetic heart disease and tangier disease. |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. |
The molecule is a thyroxine treatment, a fat storage, and a nutrient. It impacts metabolic syndrome, cardiovascular disease, pancreatitis, and atherosclerosis. |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts diabetic heart disease, aging, and tangier disease. |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. |
The molecule is a schizophrenia treatment. |
The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts diabetic heart disease, aging, and tangier disease. |
The molecule is a energy storage, inflammatory, energy source that impacts obesity, metabolic syndrome, and pancreatitis. The molecule is a nutrient that impacts both cardiovascular disease and cancer. The molecule is a membrane stabilizer and a fat storage, it impacts atherosclerosis, and is thyroxine treatment. |
The molecule is a hiv integrase inhibitor, a aids treatment, and anti viral. |
It belongs to the anti biotic class of molecules. |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts tangier disease and diabetic heart disease. |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, aging, and diabetic heart disease. |
The molecule is a nutrient, green, licorice, petroleum, vegetable skin. The molecule is a flavoring agent, waxy, rue, fresh, clean. |
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts tangier disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts aging and non-alcoholic fatty liver disease. |
The molecule is a energy source, membrane stabilizer, and inflammatory that has an effect on cancer and impacts both metabolic syndrome and cardiovascular disease. The molecule is a nutrient and thyroxine treatment, and it impacts atherosclerosis. The molecule is a energy storage and a fat storage, impacting both pancreatitis and obesity. |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts aging, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts tangier disease and barth syndrome. |
The molecule is a dgat inhibitor and belongs to the obesity treatment class of molecules. |
The molecule is a platelet aggregation inhibitor. |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. |
The molecule is a protein kinase inhibitor that impacts cancer treatment. |
The molecule is a immunomodulator that is anti viral agent and anti viral. |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, barth syndrome, and tangier disease. |